113981-44-5 cefozopran hydrochloride
| post date: | dec 07,2021 |
| expiry date: | dec 07,2022 |
| detailed description: |
cas no. :113981-44-5;125905-00-2
identification molecular structure molecular formula c19h17n9o5s2.hcl |
| cas registry number: |
113981-44-5;125905-00-2 |
| synonyms: | (6r,7r)-7-[[(2e)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-methoxyiminoacetyl]amino]-3-(imidazo[2,3-f]pyridazin-4-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid chloride;cefozopran hcl;1-{[(6r,7r)-7-{[(2z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(methoxyimino)acetyl]amino}-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl}-1h-imidazo[1,2-b]pyridazin-4-ium chloride;[6r-[6alpha,7beta(z)]]-1-[[7-[[(5-amino-1,2,4-thiadiazol-3-yl)(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1h-imidazo[1,2-b]pyridazinium chloride;sce-2787.hcl;firstcin;(6r,7r)-7-[2-(5-amino-1,2,4-thiadiazol-3-yl)-2(z)-(methoxyimino)acetamido]-3-(imidazo[1,2-b]pyridazinio-1-ylmethyl)-3-cephem-4-carboxylate hydrochloride; |
| molecular formula: | c19h18cln9o5s2 |
| molecular weight: | 551.9865 |
| molecular structure: | 
|